Your browser doesn't support javascript.
loading
ASO Author Reflections: mLST8 is a Prognostic Biomarker and Involved in Tumor Progression in Hepatocellular Carcinoma.
Yu, Xiang-Nan; Shen, Xi-Zhong; Guo, Hong-Ying; Zhu, Ji-Min.
Affiliation
  • Yu XN; Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shen XZ; Shanghai Institute of Liver Disease, Shanghai, China.
  • Guo HY; Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhu JM; Shanghai Institute of Liver Disease, Shanghai, China.
Ann Surg Oncol ; 27(5): 1558-1559, 2020 May.
Article in En | MEDLINE | ID: mdl-32166592
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / MTOR Associated Protein, LST8 Homolog / Liver Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2020 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / MTOR Associated Protein, LST8 Homolog / Liver Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2020 Type: Article Affiliation country: China